Prudential Financial’s HOOKIPA Pharma HOOK Stock Holding History

Prudential Financial’s Portfolio HOOK Stock Details HOOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-28,800	Closed	-$31.1K	–	2464
2025 Q1	$31.1K	Buy	28,800 +17,400	+153%	+$28.7K	﹤0.01%	2229
2024 Q4	$22.9K	Buy	+11,400	New	+$35.3K	﹤0.01%	2269
2024 Q3	–	Sell	-6,460	Closed	-$38.2K	–	2744
2024 Q2	$38.2K	Hold	6,460	–	–	﹤0.01%	2641
2024 Q1	$46K	Buy	+6,460	New	+$46K	﹤0.01%	2595
2023 Q3	–	Sell	-3,920	Closed	-$34.5K	–	2636
2023 Q2	$34.5K	Hold	3,920	–	–	﹤0.01%	2569
2023 Q1	$28.9K	Hold	3,920	–	–	﹤0.01%	2548
2022 Q4	$31.8K	Buy	3,920 +2,640	+206%	+$28.6K	﹤0.01%	2536
2022 Q3	$17K	Hold	1,280	–	–	﹤0.01%	2633
2022 Q2	$21K	Buy	+1,280	New	+$21.2K	﹤0.01%	2645

Other funds holding HOOK

Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Prudential Financial's HOOK Position: Q2 2025 in Review

Prudential Financial sold out of HOOKIPA Pharma (HOOK) in Q2 2025, closing a stake of 28,800 shares — an estimated $31.1K sold.

Prudential Financial first reported a position in HOOK in Q2 2022 and held it in 9 quarters. The position peaked at $46K in Q1 2024. 27 funds tracked by Wall St. Rank hold HOOK as of Q2 2025.

Prudential Financial reported no remaining HOOKIPA Pharma position as of Q2 2025 after selling out during the quarter.
Prudential Financial sold 28,800 HOOKIPA Pharma shares in Q2 2025, an estimated $31.1K.
Prudential Financial first reported a position in HOOKIPA Pharma in Q2 2022 and held it in 9 quarters.
Prudential Financial's HOOKIPA Pharma position peaked at $46K in Q1 2024.
27 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q2 2025.

Based on Prudential Financial's 13F filing for Q2 2025, filed 12 Aug 2025.